X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5661) 5661
Newsletter (10) 10
Magazine Article (9) 9
Book Chapter (8) 8
Book Review (3) 3
Conference Proceeding (2) 2
Publication (2) 2
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5262) 5262
ticlopidine - analogs & derivatives (4823) 4823
male (3384) 3384
female (3016) 3016
ticlopidine - administration & dosage (2769) 2769
clopidogrel (2622) 2622
middle aged (2529) 2529
platelet aggregation inhibitors - administration & dosage (2394) 2394
aged (2334) 2334
ticlopidine - therapeutic use (2276) 2276
platelet aggregation inhibitors - therapeutic use (2114) 2114
aspirin (1857) 1857
cardiac & cardiovascular systems (1759) 1759
treatment outcome (1529) 1529
aspirin - administration & dosage (1448) 1448
ticlopidine - adverse effects (1436) 1436
drug therapy, combination (1379) 1379
platelet aggregation inhibitors - adverse effects (1365) 1365
aspirin - therapeutic use (1255) 1255
percutaneous coronary intervention (1116) 1116
peripheral vascular disease (928) 928
platelet aggregation - drug effects (925) 925
risk factors (920) 920
stents (901) 901
ticlopidine - pharmacology (865) 865
time factors (833) 833
abridged index medicus (822) 822
antiplatelet therapy (820) 820
adult (807) 807
hematology (797) 797
platelet aggregation inhibitors - pharmacology (780) 780
ticlopidine (730) 730
thrombosis (718) 718
acute coronary syndromes (690) 690
pharmacology & pharmacy (680) 680
prospective studies (670) 670
aspirin - adverse effects (646) 646
drug therapy (643) 643
myocardial-infarction (629) 629
risk (614) 614
cardiovascular (602) 602
therapy (580) 580
blood platelets - drug effects (572) 572
follow-up studies (556) 556
aged, 80 and over (553) 553
heart attacks (543) 543
acute coronary syndrome - drug therapy (534) 534
angioplasty, balloon, coronary (534) 534
blood platelets (528) 528
dose-response relationship, drug (503) 503
medicine, general & internal (490) 490
cardiac patients (488) 488
care and treatment (488) 488
coronary heart disease (487) 487
stroke (480) 480
prasugrel (478) 478
retrospective studies (478) 478
hemorrhage - chemically induced (475) 475
aggregation (465) 465
cardiology (464) 464
animals (437) 437
drug administration schedule (433) 433
drug-eluting stents (427) 427
drug interactions (426) 426
intervention (415) 415
prevention (404) 404
platelet function tests (400) 400
inhibition (393) 393
dosage and administration (389) 389
trial (389) 389
analysis (388) 388
stent (384) 384
ticlopidine - pharmacokinetics (383) 383
myocardial infarction - drug therapy (381) 381
thrombosis - prevention & control (375) 375
adenosine - analogs & derivatives (374) 374
mortality (370) 370
surgery (369) 369
risk assessment (368) 368
platelets (365) 365
prasugrel hydrochloride (361) 361
administration, oral (355) 355
outcomes (350) 350
platelet reactivity (343) 343
platelet aggregation inhibitors - pharmacokinetics (339) 339
double-blind method (337) 337
medicine & public health (335) 335
cardiovascular disease (334) 334
angioplasty (325) 325
stent thrombosis (325) 325
acute coronary syndrome (323) 323
coronary artery disease - drug therapy (312) 312
randomized controlled trials as topic (311) 311
myocardial infarction - therapy (310) 310
platelet activation - drug effects (306) 306
coronary angiography (304) 304
cardiovascular diseases (299) 299
resistance (299) 299
anticoagulants - administration & dosage (296) 296
transluminal angioplasty (296) 296
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5293) 5293
German (128) 128
Japanese (98) 98
Russian (57) 57
French (43) 43
Spanish (37) 37
Italian (34) 34
Chinese (20) 20
Polish (17) 17
Swedish (10) 10
Danish (9) 9
Hungarian (8) 8
Ukrainian (5) 5
Norwegian (4) 4
Turkish (4) 4
Czech (3) 3
Portuguese (3) 3
Croatian (2) 2
Dutch (2) 2
Hebrew (2) 2
Lithuanian (2) 2
Finnish (1) 1
Korean (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 12/2010, Volume 122, Issue 24, pp. 2619 - 2633
proton pump inhibitors | antiplatelet drugs | gastrointestinal hemorrhage | platelet aggregation inhibitors | aspirin | thienopyridine | AHA Scientific Statements | CYTOCHROME-P450 | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | ACID SUPPRESSION | PERCUTANEOUS CORONARY INTERVENTION | CLOPIDOGREL | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | DISEASE | PERIPHERAL VASCULAR DISEASE | PRASUGREL | PEPTIC-ULCERS | Piperazines - administration & dosage | Prasugrel Hydrochloride | Purinergic P2Y Receptor Antagonists - administration & dosage | Thiophenes - adverse effects | Cardiovascular Diseases - drug therapy | Humans | Thienopyridines - adverse effects | Thienopyridines - metabolism | Piperazines - metabolism | Thiophenes - metabolism | Thiophenes - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - metabolism | Histamine H2 Antagonists - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Aspirin - adverse effects | Aspirin - metabolism | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - metabolism | Ticlopidine - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Platelet Aggregation Inhibitors - metabolism | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Proton Pump Inhibitors - adverse effects | Thienopyridines - administration & dosage | Risk Factors | Histamine H2 Antagonists - adverse effects | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Aryl Hydrocarbon Hydroxylases - metabolism | Gastrointestinal Hemorrhage - chemically induced | Gastrointestinal Hemorrhage - prevention & control | Histamine H2 Antagonists - metabolism | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Cytochrome P-450 CYP2C19 | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Proton Pump Inhibitors - metabolism
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 23, pp. 2155 - 2166
Patients who had received a drug-eluting stent and then dual antiplatelet therapy for 12 months were randomly assigned to 18 more months of therapy or aspirin... 
TRIALS | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | MULTICENTER | CLOPIDOGREL | TICAGRELOR | THROMBOSIS | RATIONALE | PREVENTION | ASPIRIN | CLINICAL-OUTCOMES | Piperazines - administration & dosage | Prasugrel Hydrochloride | Thiophenes - adverse effects | Humans | Middle Aged | Male | Thiophenes - administration & dosage | Aspirin - administration & dosage | Incidence | Time Factors | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Myocardial Ischemia - mortality | Thrombosis - prevention & control | Drug Therapy, Combination | Myocardial Ischemia - epidemiology | Platelet Aggregation Inhibitors - adverse effects | Drug-Eluting Stents | Drug Administration Schedule | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Myocardial Ischemia - therapy | Aged | Hemorrhage - chemically induced | Aggregation | Treatment outcome | Care and treatment | Usage | Blood platelets | Analysis | Drug-eluting stents | Dosage and administration | Cardiovascular diseases | Thrombosis | Health aspects | Blood clot | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Drug delivery | Patients | Bleeding | Clinical outcomes | Cerebrovascular system | Coronary vessels | Implants | Clopidogrel | Drug therapy | Stents
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 12/2010, Volume 105, Issue 12, pp. 2533 - 2549
This expert consensus document was developed by the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG), and the... 
proton pump inhibitors | aspirin | ACCF Expert Consensus Document antiplatelet drugs | gastrointestinal hemorrhage | thienopyridine | platelet aggregation inhibitors | CYTOCHROME-P450 | MYOCARDIAL-INFARCTION | ACID SUPPRESSION | PERCUTANEOUS CORONARY INTERVENTION | CLOPIDOGREL | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | DISEASE | PRASUGREL | GASTROENTEROLOGY & HEPATOLOGY | PEPTIC-ULCERS | Piperazines - administration & dosage | Prasugrel Hydrochloride | Purinergic P2Y Receptor Antagonists - administration & dosage | Thiophenes - adverse effects | Cardiovascular Diseases - drug therapy | Humans | Thienopyridines - adverse effects | Thienopyridines - metabolism | Piperazines - metabolism | Thiophenes - metabolism | Thiophenes - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - metabolism | Histamine H2 Antagonists - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Aspirin - adverse effects | Aspirin - metabolism | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - metabolism | Ticlopidine - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Platelet Aggregation Inhibitors - metabolism | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Proton Pump Inhibitors - adverse effects | Thienopyridines - administration & dosage | Risk Factors | Histamine H2 Antagonists - adverse effects | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Aryl Hydrocarbon Hydroxylases - metabolism | Gastrointestinal Hemorrhage - chemically induced | Gastrointestinal Hemorrhage - prevention & control | Histamine H2 Antagonists - metabolism | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Cytochrome P-450 CYP2C19 | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Proton Pump Inhibitors - metabolism
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 367, Issue 22, pp. 2100 - 2109
Journal Article
Canadian Medical Association journal (CMAJ), ISSN 1488-2329, 2011, Volume 183, Issue 16, pp. 1835 - 1843
Background: Patients prescribed antiplatelet treatment to prevent recurrent acute myocardial infarction are often also given a selective serotonin reuptake... 
DEPRESSION | ESOMEPRAZOLE | MEDICINE, GENERAL & INTERNAL | ANTIDEPRESSANTS | CLOPIDOGREL | EVENTS | PROGNOSIS | DRUGS | ELDERLY-PATIENTS | ASPIRIN | Age Factors | Anemia - epidemiology | Angioplasty | Humans | Middle Aged | Citalopram - adverse effects | Male | Risk | Secondary Prevention | Sertraline - adverse effects | Peptic Ulcer - epidemiology | Adrenal Cortex Hormones - therapeutic use | Renal Insufficiency - epidemiology | Aspirin - administration & dosage | Paroxetine - adverse effects | Paroxetine - administration & dosage | Fluvoxamine - administration & dosage | Canada - epidemiology | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Retrospective Studies | Drug Therapy, Combination | Heart Failure - epidemiology | Fluoxetine - adverse effects | Platelet Aggregation Inhibitors - adverse effects | Hypoglycemic Agents - therapeutic use | Hemorrhage - epidemiology | Risk Factors | Serotonin Uptake Inhibitors - adverse effects | Anticoagulants - therapeutic use | Antihypertensive Agents - therapeutic use | Fluvoxamine - adverse effects | Ticlopidine - analogs & derivatives | Citalopram - administration & dosage | Sertraline - administration & dosage | Serotonin Uptake Inhibitors - administration & dosage | Fluoxetine - administration & dosage | Sex Factors | Aged | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Neoplasms - epidemiology | Cohort Studies | Aggregation | Complications and side effects | Blood platelets | Patient outcomes | Serotonin uptake inhibitors | Dosage and administration | Drug therapy | Hemorrhage | Heart attack | Risk factors | Studies | Side effects | Heart attacks | Inhibitor drugs | Research
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2007, Volume 49, Issue 24, pp. 2312 - 2317
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 58, Issue 22, pp. 2263 - 2269
Chronic kidney disease (CKD) is prevalent and affects an ever-increasing proportion of patients presenting with acute coronary syndrome (ACS). Patients with... 
Cardiovascular | Internal Medicine | non–ST-segment elevation myocardial infarction | chronic kidney disease | bleeding | ST-segment elevation myocardial infarction | unstable angina | acute coronary syndrome(s) | antiplatelet | antithrombotic | nonST-segment elevation myocardial infarction | CARDIAC & CARDIOVASCULAR SYSTEMS | WAVE MYOCARDIAL-INFARCTION | HIGH-RISK PATIENTS | GLYCOPROTEIN IIB/IIIA INHIBITORS | non-ST-segment elevation myocardial infarction | MOLECULAR-WEIGHT HEPARIN | PLATELET INHIBITION | DOUBLE-BLIND | ST-SEGMENT ELEVATION | STAGE RENAL-DISEASE | UNFRACTIONATED HEPARIN | ARTERY-DISEASE | Piperazines - administration & dosage | Prasugrel Hydrochloride | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Heparin - administration & dosage | Thiophenes - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Aspirin - administration & dosage | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Acute Coronary Syndrome - complications | Aspirin - adverse effects | Adenosine - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Polysaccharides - administration & dosage | Kidney Diseases - complications | Platelet Aggregation Inhibitors - adverse effects | Peptide Fragments - administration & dosage | Polysaccharides - adverse effects | Clinical Trials as Topic | Uremia - complications | Adenosine - administration & dosage | Piperazines - adverse effects | Recombinant Proteins - administration & dosage | Ticlopidine - analogs & derivatives | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Acute Coronary Syndrome - drug therapy | Adenosine - analogs & derivatives | Hirudins - adverse effects | Fibrinolytic Agents - administration & dosage | Peptide Fragments - adverse effects | Hemorrhage - chemically induced | Chronic Disease | Care and treatment | Chronic kidney failure | Cardiac patients | Cardiology | Coronary heart disease | Health aspects | Cardiovascular agents | Medical colleges | Mortality | Heart attacks | Drug therapy | Acute coronary syndromes | Coronary vessels
Journal Article
Journal Article
Canadian Journal of Cardiology, ISSN 0828-282X, 2013, Volume 29, Issue 11, pp. 1334 - 1345
Abstract The initial 2010 Canadian Cardiovascular Society (CCS) Guidelines for the Use of Antiplatelet Therapy in the Outpatient Setting were published in May... 
Cardiovascular | PERCUTANEOUS CORONARY INTERVENTION | ISCHEMIC EVENTS | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | PLATELET INHIBITION | ANTITHROMBOTIC THERAPY | DOUBLE-BLIND | TRITON-TIMI 38 | DOSE CLOPIDOGREL | PROTON-PUMP INHIBITORS | ARTERY-DISEASE | Piperazines - administration & dosage | Prasugrel Hydrochloride | Anticoagulants - administration & dosage | Humans | Hemorrhage - prevention & control | Secondary Prevention | Thiophenes - administration & dosage | Aspirin - administration & dosage | Contraindications | Dose-Response Relationship, Drug | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Aspirin - adverse effects | Adenosine - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Thrombosis - prevention & control | Drug Therapy, Combination | Stents | Platelet Aggregation Inhibitors - adverse effects | Proton Pump Inhibitors - adverse effects | Stroke - prevention & control | Drug Administration Schedule | Clinical Trials as Topic | Adenosine - administration & dosage | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Coronary Artery Bypass | Acute Coronary Syndrome - therapy | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Percutaneous Coronary Intervention
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 379, Issue 3, pp. 215 - 225
In this international, randomized trial, patients with minor stroke or TIA who received clopidogrel plus aspirin had a lower risk of major ischemic events but... 
TRIAL | MEDICINE, GENERAL & INTERNAL | EFFICACY | TICAGRELOR | SAFETY | MINOR STROKE | ATTACK | Stroke - prevention & control | Ischemic Attack, Transient - drug therapy | Double-Blind Method | Humans | Middle Aged | Male | Risk | Brain Ischemia - prevention & control | Secondary Prevention | Stroke - drug therapy | Ischemia - mortality | Ticlopidine - analogs & derivatives | Aspirin - administration & dosage | Drug Therapy, Combination - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Clopidogrel | Female | Aged | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Platelet Aggregation Inhibitors - adverse effects | Stroke (Disease) | Cerebral ischemia | Safety and security measures | Dosage and administration | Drug therapy | Stroke patients | Health aspects | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Nuclear magnetic resonance--NMR | Medical imaging | Transient ischemic attack | Hemorrhage | Neurological diseases | Ischemia | Blood platelets | Tomography | Blood pressure | Diabetes | Drug dosages | Neurological disorders | Brain Ischemia | Ischemic Attack | administration & dosage | Combination | Transient | Neurologi | chemically induced | Drug Therapy | prevention & control | Ticlopidine | Neurology | Myocardial Infarction | analogs & derivatives | Platelet Aggregation Inhibitors | adverse effects | mortality
Journal Article